Identification of CD16-2, a novel mouse receptor homologous to CD16/FcγRIII
Identification of CD16-2, a novel mouse receptor homologous to CD16/FcγRIII
复制标题
DOI:
10.1007/s00251-002-0486-0
复制
发表时间:
2002-10-01
期刊:
影响因子:
3.2
通讯作者:
Taranin, AV
中科院分区:
文献类型:
--
作者:
Mechetina, LV;Najakshin, AM;Taranin, AV
It is believed that mouse FcgammaRIII arose by an evolutionarily recent recombination, which brought together the extracellular domains from FcgammaRII with the transmembrane/cytoplasmic region from the ancestor FcgammaRIII. Here, we report identification of a mouse gene encoding a transmembrane receptor that may be regarded as the true ortholog of nonrodent CD16/FcgammaRIII. Designated CD16-2, the novel protein is highly similar to human FcgammaRIIIA in the signal peptide (60% identical residues), and in the extracellular domains (65%). Although the similarity between the two proteins is less conspicuous in the transmembrane/cytoplasmic region (54%), it is higher than between human FcgammaRIIIA and mouse FcgammaRIII (44%). However, the conserved transmembrane motif LFAVDTGL shared by rodent and human FcgammaRIII and FCepsilonRI has two replacements in CD16-2. The CD16-2 gene is tightly linked to the FcgammaRIII and FcgammaRII genes and consists of five exons. Northern blot analysis revealed that CD16-2 is expressed in peripheral blood leukocytes, as well as in spleen, thymus, colon and intestine. RT-PCR showed prominent expression in macrophage cell line J774. Based on sequence comparisons, it is suggested that the modern repertoire of the mammalian low affinity Fc receptors has resulted from repetitive duplications and/or recombinations of three ancestral genes.